Catatonia Diagnosis and Treatment

Clinical Presentation

Catatonia is recognized as an independent neuropsychiatric syndrome with distinct clinical presentations, including retarded/inhibited, excited, and malignant forms, each requiring specific recognition and treatment approaches 1
The retarded (inhibited) form is characterized by stupor, immobility, mutism, negativism, posturing, catalepsy, waxy flexibility, and rigidity, with automatic obedience and echo phenomena (echolalia, echopraxia) possibly present 1
The excited form presents with psychomotor agitation, impulsivity, combativeness, and stereotypies, including grimacing and bizarre behavior 1
The malignant form is the most severe and life-threatening, with autonomic instability, including labile blood pressure, hyperthermia, diaphoresis, and altered vital signs 2, 3

A diagnosis of catatonia requires three or more of the following 11 signs: immobility/stupor, mutism, negativism, oppositionism/gegenhalten, posturing, catalepsy/waxy flexibility, automatic obedience, echo phenomena, rigidity, verbigeration, and withdrawal/refusal to eat or drink, with a sensitivity of 100% and specificity of 99% 3

For malignant catatonia, initiate ECT immediately without benzodiazepine trial when autonomic instability or hyperthermia is present, using bilateral electrode placement for critically ill patients 2, 3
For non-malignant catatonia, administer lorazepam 2.5 mg oral challenge initially, rating catatonic signs after the first hour, and proceed to ECT if lorazepam fails after adequate trial 2, 3
Monitor for at least 24 hours post-ECT for complications, including tardive seizures 3

Do not delay benzodiazepine or ECT trials by pursuing extensive differential diagnosis in severe cases, as catatonia can be rapidly fatal 2
Never attribute catatonic symptoms to medication side effects without considering primary catatonia, as drug-induced parkinsonism can mimic catatonia 4
Distinguish from neuroleptic malignant syndrome and serotonin syndrome, and avoid physical restraints as they worsen hyperthermia and lactic acidosis through isometric contractions 4, 5

Fever is a well-established trigger that warrants early and aggressive temperature reduction measures, according to the American College of Cardiology 6, 7

Physiological stressors including surgery and acute medical illnesses represent significant risk factors, as reported in Gastroenterology 8, 9
Acute infections, particularly CNS infections, can precipitate catatonic episodes, and the American College of Cardiology recommends aggressive treatment of fever 6, 7

Psychological stress—both negative and positive—triggers catatonic episodes in susceptible patients, as confirmed in Gastroenterology 8, 9
Stress is confirmed as a trigger in approximately 70-80% of patients with episodic conditions, similar to catatonia, according to Gastroenterology 8, 9

Excessive alcohol intake and cocaine use are identified as potential triggers, as reported in the Journal of the American College of Cardiology 6, 7
Certain psychotropic medications beyond antipsychotics can trigger catatonia, and the American College of Cardiology recommends caution with these medications 6, 7

Implement trigger avoidance strategies, including aggressive treatment of fever, minimizing antipsychotic exposure, and addressing modifiable triggers such as stress management and sleep hygiene, as recommended in Gastroenterology 8, 9